Infinity Health Africa and IntraHub Unite to Revolutionize Pharma Compliance in Africa
In a strategic partnership that could redefine Africa’s pharmaceutical landscape, Nigeria-based regulatory technology firm Infinity Health Africa has joined forces with IntraHub Africa, a leading pharmacovigilance service provider. Together, the companies aim to automate and digitize regulatory compliance and drug safety processes, addressing longstanding challenges in the continent’s growing pharmaceutical industry.
Building a Digital Backbone for Compliance
The cornerstone of this collaboration is the integration of Infinity Health’s digital infrastructure with IntraHub’s pharmacovigilance technology, offering pharmaceutical companies a comprehensive, end-to-end compliance and quality assurance solution.
Infinity Health brings to the table its proprietary platform ONBOARD, designed to manage the entire product lifecycle—from drug registration and licensing to post-marketing surveillance. ONBOARD helps companies streamline regulatory submissions, track progress, and maintain up-to-date compliance records.
Meanwhile, IntraHub contributes its IntraVigi™ platform, a specialized tool for monitoring adverse drug reactions (ADRs) and generating international-standard safety reports. This system allows drug manufacturers and healthcare providers to proactively manage drug safety and meet global pharmacovigilance standards.
Addressing Africa’s Regulatory Gaps
While Africa’s pharmaceutical market is on track to reach $70 billion by 2030, the path is littered with regulatory hurdles. Fragmented policies, paper-based systems, and underdeveloped pharmacovigilance frameworks have historically limited the sector’s growth and global competitiveness.
Regulators across the continent are beginning to raise the bar. For example, Nigeria’s NAFDAC now mandates bioequivalence studies for all generic drugs submitted for approval, while Kenya’s Pharmacy and Poisons Board introduced stringent new rules around pharmacovigilance in 2022. These developments signal a continent-wide push for higher safety and manufacturing standards.
“In Africa, the lack of quality documentation remains a significant bottleneck in achieving regulatory compliance,” said Irene Nwaukwa, CEO of Infinity Health Africa. “This partnership is designed to address that—by offering companies digital tools and expert support to register products, document safety data, and ultimately protect patient lives.”
Driving Growth Through Innovation
Together, the two companies aim to:
- Enhance regulatory documentation and submission processes
- Improve readiness for Good Manufacturing Practice (GMP) certification
- Simplify ADR tracking and analysis
- Support local and international regulatory audits
- Promote patient safety through advanced pharmacovigilance systems
“This is about more than compliance—it’s about building trust and safety in Africa’s healthcare ecosystem,” said Pharm. Abubakar Mukhtar, CEO of IntraHub Africa. “With this alliance, we’re helping African pharma companies compete on a global stage while putting patient safety at the core.”
Proven Expertise and a Pan-African Vision
Having managed over 200 regulatory submissions between them, Infinity Health and IntraHub are no strangers to the complexities of Africa’s regulatory environment. Their combined expertise and digital-first approach make them well-positioned to shape a smarter, more responsive regulatory ecosystem across the continent.
As pharmaceutical companies look to scale responsibly and sustainably, this partnership represents a major leap toward regulatory excellence, digital transformation, and better health outcomes across Africa.
